FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083040802> ?p ?o ?g. }

• W2083040802 endingPage "381" @default.
• W2083040802 startingPage "378" @default.
• W2083040802 abstract "Expert Opinion Oral Methylergonovine Maleate for Refractory Migraine and Cluster Headache Prevention Joel R. Saper MD, FACP, FAAN, Corresponding Author Joel R. Saper MD, FACP, FAAN Michigan Head-Pain & Neurological Institute, Ann Arbor, MI, USAAddress all correspondence to J.R. Saper, Michigan Head-Pain & Neurological Institute, Ann Arbor, MI 48104, USA.Search for more papers by this authorRandolph W. Evans MD, Randolph W. Evans MD Baylor College of Medicine, Houston, TX, USASearch for more papers by this author Joel R. Saper MD, FACP, FAAN, Corresponding Author Joel R. Saper MD, FACP, FAAN Michigan Head-Pain & Neurological Institute, Ann Arbor, MI, USAAddress all correspondence to J.R. Saper, Michigan Head-Pain & Neurological Institute, Ann Arbor, MI 48104, USA.Search for more papers by this authorRandolph W. Evans MD, Randolph W. Evans MD Baylor College of Medicine, Houston, TX, USASearch for more papers by this author First published: 22 February 2013 https://doi.org/10.1111/head.12033Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Stoll A, Hofmann A. Alkaloids of the ergotamine group. Helv Chim Acta. 1943; 26: 1570- 1601. 2 Tfelt-Hansen P, Jansen I, Edvinsson L. Methylergometrine antagonizes 5HT in the temporal artery. Eur J Clin Pharmacol. 1987; 33: 77- 79. 3 MacLennan SJ, Martin GR. Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction. Naunyn Schmiedebergs Arch Pharmacol. 1990; 342: 120- 129. 4 Silberstein SD. Methysergide. Cephalalgia. 1998; 18: 421- 435. 5 Raskin NH, Schwartz RK. Interval therapy of migraine: Long-term results. Headache. 1980; 20: 336- 340. 6 Saper JR, Silberstein S, Gordon CD, Hamel RL. Handbook of Headache Management. Baltimore, MD: Williams and Wilkins; 1993: 35- 82. 7 Golden GS. Pharmacologic therapy for headaches in children. In: RM Gallagher, ed. Drug Therapy for Headache. New York: Marcel Dekker, Inc; 1991: 173- 181. 8 Gallagher RM. Pharmacologic treatment of cluster headache. In: RM Gallagher, ed. Drug Therapy for Headache. New York: Marcel Dekker, Inc; 1991: 131- 150. 9 Graff-Radford SB, Bittar GT. The use of methylergonovine in the initial control of drug-induced refractory headache. Headache. 1993; 33: 390- 393. 10 Mueller L, Gallagher IM, Ciervo CA. Methylergonovine maleate as a cluster headache prophylactic: A study in review. Headache. 1997; 37: 437- 442. 11 Gallagher RM. Menstrual migraine and intermittent ergonovine therapy. Headache. 1989; 29: 366- 367. 12 Hakim S, Khan RM, Maroof M, Usmani H, Huda W, Jafri F. Methylergonovine (Methergine) relieves post-dural puncture headache in obstetric patients. ACTA Obstet Gynecol Scand. 2005; 84: 100. 13 Henry PY, Larre P, Aupy M, et al. Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia. 1984; 4: 171- 178. 14 Igarashi Y, Yamozoe M, Shibata A. Effect of direct intracoronary administration of methylergonovine in patients with and without variant angina. Am Heart J. 1991; 121: 1094- 1100. 15 Golino P, Maseri A. Serotonin receptors in human coronary arteries. Circulation. 1994; 90: 1573- 1575. 16 Mantyla R, Kleimola T, Kanto J. Methylergometrine (methylergonovine) concentrations in the human plasma and urine. Int J Clin Pharmacol Biopharm. 1978; 16: 254- 257. 17 Bredberg U, Eyjolfsdottir G, Paalzow L, Tfelt-Hansen P, Tfelt-Hansen V. Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharmacol. 1986; 30: 75- 77. 18 Bucci JA, Manoharan A. Methysergide-induced retroperitoneal fibrosis: Successful outcome in two new laboratory features. Mayo Clin Proc. 1997; 72: 1148- 1150. 19 Graham JR. Cardiac and pulmonary fibrosis during methysergide therapy for headache. Am J Med Sci. 1967; 254: 1- 12. 20 Graham JR, Sube HI, LeCompte PM, Sudowsky NL. Inflammatory fibrosis associated with methysergide therapy. Res Clin Stud Headache. 1967; 1: 123- 164. 21 Bana DS, MacNeal PS, LeCompte PM, Shah Y, Graham JR. Cardiac murmurs and endocardial fibrosis associated with methysergide therapy. Am Heart J. 1974; 88: 640- 655. 22 Rothman RB, Baumann MH, Savage JE, et al. Evidence of possible involvement in the 5-HT (2b) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medicines. Circulation. 2000; 102: 2836- 2841. 23 Mylecharane EJ. 5-HT2 receptor antagonists and migraine therapy. J Neurol. 1991; 238(Suppl. 1): S45- S52. 24 Hofmann C, Penner U, Dorow R, et al. Lisuride, dopamine receptor agonists with 5-HT(2b) receptor antagonist properties: Absence of cardiac valvulopathy adverse drug reaction supports the concept of a crucial role in 5-HT(2b) receptor agonism in cardiac valvular fibrosis. Clin Neuropharmacol. 2006; 29: 80- 86. 25 Schiff P. Ergot and its alkaloids. Am J Pharm Educ. 2006; 70: 1- 10. Citing Literature Volume53, Issue2February 2013Pages 378-381 ReferencesRelatedInformation" @default.
• W2083040802 created "2016-06-24" @default.
• W2083040802 creator A5057384130 @default.
• W2083040802 creator A5057671317 @default.
• W2083040802 date "2013-02-01" @default.
• W2083040802 modified "2023-10-17" @default.
• W2083040802 title "Oral Methylergonovine Maleate for Refractory Migraine and Cluster Headache Prevention" @default.
• W2083040802 cites W1973660081 @default.
• W2083040802 cites W1974089284 @default.
• W2083040802 cites W1975727791 @default.
• W2083040802 cites W1976744941 @default.
• W2083040802 cites W1977145463 @default.
• W2083040802 cites W1984646309 @default.
• W2083040802 cites W1986711310 @default.
• W2083040802 cites W1993117784 @default.
• W2083040802 cites W1998573871 @default.
• W2083040802 cites W2010754787 @default.
• W2083040802 cites W2018471307 @default.
• W2083040802 cites W2073672302 @default.
• W2083040802 cites W2074348348 @default.
• W2083040802 cites W2081070034 @default.
• W2083040802 cites W2081433074 @default.
• W2083040802 cites W2085001535 @default.
• W2083040802 cites W2127750838 @default.
• W2083040802 cites W2169946407 @default.
• W2083040802 cites W2196566018 @default.
• W2083040802 doi "https://doi.org/10.1111/head.12033" @default.
• W2083040802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23432443" @default.
• W2083040802 hasPublicationYear "2013" @default.
• W2083040802 type Work @default.
• W2083040802 sameAs 2083040802 @default.
• W2083040802 citedByCount "9" @default.
• W2083040802 countsByYear W20830408022013 @default.
• W2083040802 countsByYear W20830408022014 @default.
• W2083040802 countsByYear W20830408022016 @default.
• W2083040802 countsByYear W20830408022017 @default.
• W2083040802 countsByYear W20830408022018 @default.
• W2083040802 countsByYear W20830408022019 @default.
• W2083040802 countsByYear W20830408022023 @default.
• W2083040802 crossrefType "journal-article" @default.
• W2083040802 hasAuthorship W2083040802A5057384130 @default.
• W2083040802 hasAuthorship W2083040802A5057671317 @default.
• W2083040802 hasConcept C118552586 @default.
• W2083040802 hasConcept C15744967 @default.
• W2083040802 hasConcept C161191863 @default.
• W2083040802 hasConcept C2777942821 @default.
• W2083040802 hasConcept C2778541695 @default.
• W2083040802 hasConcept C41008148 @default.
• W2083040802 hasConcept C71924100 @default.
• W2083040802 hasConceptScore W2083040802C118552586 @default.
• W2083040802 hasConceptScore W2083040802C15744967 @default.
• W2083040802 hasConceptScore W2083040802C161191863 @default.
• W2083040802 hasConceptScore W2083040802C2777942821 @default.
• W2083040802 hasConceptScore W2083040802C2778541695 @default.
• W2083040802 hasConceptScore W2083040802C41008148 @default.
• W2083040802 hasConceptScore W2083040802C71924100 @default.
• W2083040802 hasIssue "2" @default.
• W2083040802 hasLocation W20830408021 @default.
• W2083040802 hasLocation W20830408022 @default.
• W2083040802 hasOpenAccess W2083040802 @default.
• W2083040802 hasPrimaryLocation W20830408021 @default.
• W2083040802 hasRelatedWork W1506200166 @default.
• W2083040802 hasRelatedWork W1995515455 @default.
• W2083040802 hasRelatedWork W2026071763 @default.
• W2083040802 hasRelatedWork W2080531066 @default.
• W2083040802 hasRelatedWork W2091990569 @default.
• W2083040802 hasRelatedWork W2748952813 @default.
• W2083040802 hasRelatedWork W2899084033 @default.
• W2083040802 hasRelatedWork W3031052312 @default.
• W2083040802 hasRelatedWork W3032375762 @default.
• W2083040802 hasRelatedWork W3108674512 @default.
• W2083040802 hasVolume "53" @default.
• W2083040802 isParatext "false" @default.
• W2083040802 isRetracted "false" @default.
• W2083040802 magId "2083040802" @default.
• W2083040802 workType "article" @default.